Cytokine gene variants/expressions and non-syndromic microtia – is there a link?

Year 2017, Volume: 7 Issue: 2, 62 - 67, 30.09.2017

Ayşe Feyda Nursal Mehmet Bekerecioğlu Sacide Pehlivan Tuğçe Sever Berker Büyükgüral

Abstract

Objective: Although many genetic and environmental factors are investigated the etiopathogenesis of microtia, it still remains unclear. We investigated the relationship between the variants/expression of pro- and anti-inflammatory cytokines [interleukin (IL) 6, IL-10, tumor necrosis factor-alpha (TNF-α), transforming growth factor beta (TGF-β1), interferon gamma (IFN-γ)] and susceptibility non-syndromic microtia in a Turkish cohort.

Methods: Nineteen unrelated cases with microtia and 40 healthy controls were included in the present study. Cytokine variants were tested by polymerase chain reaction with sequence-specific primers (PCR-SSP) method.

Results: It was found that IL-6 (-174) GG genotype (high expression) was higher in microtia cases than the controls (p=0.010) while IL-6 (-174) GC (high expression) genotype was lower in patients (p=0.003). For IL-6 (-174), patients with GG genotype had a 5895-fold increased risk for microtia. IFN-γ (+874) variant AA genotype (low expression) was lower in microtia cases (p=0.009). IL-6 (-174) Gallele was more prevalent in patient group compared to controls while C allele was lower in patients than controls (p=0.003). IFN-γ (+874) variant T allele was more prevalent in cases while A allele was lowerin cases (p=0.017). Conclusion: We have demonstrated for the first time that the cytokine variants constitute risk factors for developing microtia. Our study suggests that the IFN-γ (+874) and IL-6 (-174) variants may be considered as a risk factor for microtia in a Turkish cohorts.

Keywords

Non-syndromic microtia, cytokine, variant, expression, Sendromik olmayan mikrotia, sitokin, varyant, ekspresyon

References

• 1. Alasti F, Van Camp G. Genetics of microtia and associated syn- dromes. J Med Genet 2009;46:361–9. 2. Calzolari F, Garani G, Sensi A, Martini A. Clinical and radiological evaluation in children with microtia. Br J Audiol 1999;33:303–12. 3. Yamauchi M, Yotsuyanagi T, Ikeda K, et al. Clinical and genet- ic analysis of microtia in Japan. J Plast Surg Hand Surg 2012;46: 330–4. 4. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006;177:4888–96. 5. Wu MY, Hill CS. TGF-beta superfamily signaling in embryon- ic development and homeostasis. Dev Cell 2009;16:329–43. 6. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma con- tributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during nor- mal murine pregnancy. J Exp Med 2000;192:259–70. 7. Toder V, Fein A, Carp H, Torchinsky A. TNF-alpha in pregnan- cy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 2003;20:73–81. 8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. 9. Karaoglan I, Pehlivan S, Namiduru M, et al. TNF-alpha, TGF- beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis. New Microbiol 2009; 32:173–8. 10. Schaid DJ, Batzler AJ, Jenkins GD, Hildebrandt MA. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilib- rium across strata. Am J Hum Genet 2006;79:1071-80. 11. Luquetti DV, Heike CL, Hing AV, Cunningham ML, Cox TC. Microtia: epidemiology and genetics. Am J Med Genet A 2012; 158A:124–39. 12. Ishimoto S, Ito K, Karino S, Takegoshi H, Kaga K, Yamasoba T. Hearing levels in patients with microtia: correlation with tempo- ral bone malformation. Laryngoscope 2007;117:461–5. 13. Artunduaga MA, Quintanilla-Dieck Mide L, Greenway S, et al. A classic twin study of external ear malformations, including microtia. N Engl J Med 2009;361:1216–8. 14. Schmid M, Schroder M, Langenbeck U. Familial microtia, meatal atresia, and conductive deafness in three siblings. Am J Med Genet 1985;22:327–32. 15. Okajima H, Takeichi Y, Umeda K, Baba S. Clinical analysis of 592 patients with microtia. Acta Otolaryngol Suppl 1996;525:18–24. 16. Dominguez F, Gadea B, Mercader A, Esteban FJ, Pellicer A, Simón C. Embryologic outcome and secretome profile of implant- ed blastocysts obtained after coculture in human endometrial epithelial cells versus the sequential system. Fertil Steril 2010;93: 774–82.e1. 17. Shen XH, Han YJ, Zhang DX, Cui XS, Kim NH. A link between the interleukin-6/Stat3 anti-apoptotic pathway and microRNA- 21 in preimplantation mouse embryos. Mol Reprod Dev 2009;76:854–62. 18. Miranda-Vilela AL, Ribeiro IF, Grisolia CK. Association between interleukin 6 -174 G/C promoter gene polymorphism and runners' responses to the dietary ingestion of antioxidant supplementation based on pequi (Caryocar brasiliense Camb.) oil: a before-after study. Genet Mol Biol 2016;39:554–66. 19. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749–95. 20. Al-Kholy W, Elsaid A, Sleem A, Fathy H, Elshazli R, Settin A. TNF- α - 308 G > A and IFN- γ + 874 A > T gene polymorphisms in Egyptian patients with lupus erythematosus. Meta Gene 2016;9:137–41. 21. Zollner U, Bischofs S, Lalic I, Zollner KP. LIF and TNF alpha concentrations in embryo culture media are predictive for embryo implantation in IVF. Asian Pacific Journal of Reproduction 2014; 1:277–82. 22. Chaouat G, Ledée-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004;134:93– 119. 23. Mosmann TR, Coffman RL. Heterogeneity of cytokine secre- tion patterns and functions of helper T cells. Adv Immunol 1989;46:111–47. 24. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, et al. Association between IL-10 gene promoter polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and susceptibility to HBV infection in an Iranian population. Hepat Mon 2016;16:e32427. 25. Wu M, Chen G, Li YP. TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, home- ostasis and disease. Bone Res 2016;4:16009. 26. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-beta superfamily expression and actions in the endometrium and pla- centa. Reproduction 2006;132:217–32.